Background
Methods
Subjects
Main diagnostic groups | Subgroups of injury | Duration, range (median) |
n (% women) | Age in years, median (range) | Differences in age, p value |
---|---|---|---|---|---|
Reference subjects | – | NA | 23 (22) | 26 (15–58) | – |
Osteoarthritisa
| – | 0–14.8 years (2.7) | 24 (42) | 64 (36–86) |
<0.001
|
Rheumatoid arthritisb
| – | 0–43.0 years (10) | 32 (63) | 64 (32–83) |
<0.001
|
Pyrophosphate arthritis | – | 0–9.8 years (0.01) | 25 (40) | 75 (41–92) |
<0.001
|
Knee injuryc
| – | 0–36.9 years (0.02) | 294 (27) | 29 (13–65) | 0.842 |
Recent injury | 0–83 days (4) | 219 (25) | 26 (13–64) | 0.705 | |
Recent injury, substratification | 0 days (0) | 35 (23) | 30 (14–47) | 0.991 | |
1 day (1) | 39 (21) | 24 (13–57) | 0.211 | ||
2–3 days (3) | 31 (29) | 26 (16–54) | 0.914 | ||
4–7 days (5) | 46 (28) | 25 (14–64) | 0.492 | ||
8–22 days (11) | 44 (30) | 23 (14–57) | 0.151 | ||
23–83 days (32) | 24 (13) | 38 (21–59) |
0.033
| ||
Old injuryd
| 1–36.9 years (3.3) | 75 (33) | 32 (18–65) | 0.090 | |
Old injury, substratification | 1–3 years (2.0) | 35 (40) | 33 (18–61) | 0.149 | |
3.01–36.9 years (5.1) | 40 (28) | 30 (18–65) | 0.121 |
Analysis of C4d, C3bBbP and sTCC in synovial fluid
Other biomarkers and cytokines
Image acquisition and analysis
Statistics and calculations
Results
Technical performance of the C4d, C3bBbP and sTCC ELISAs with synovial fluid
Concentrations of C4d, C3bBbP and sTCC in synovial fluid were higher in the arthritis groups than in the reference group
Concentrations of C4d, C3bBbP and sTCC in synovial fluid were higher in the knee injury group than in the reference group
Correlation between activated complement products
Reference (n = 23) | Osteoarthritis (n = 24) | Rheumatoid arthritis (n = 32) | ||||
---|---|---|---|---|---|---|
C4d | C3bBbP | C4d | C3bBbP | C4d | C3bBbP | |
C3bBbP |
0.428 (0.041)
| – | 0.080 (0.710) | – |
0.536 (0.002)
| – |
sTCC |
0.625 (0.001)
| 0.409 (0.053) |
0.754 (<0.001)
| –0.298 (0.157) |
0.752 (<0.001)
|
0.509 (0.003)
|
Pyrophosphate arthritis (n = 25) | Knee injury (n = 294) | |||||
C4d | C3bBbP | C4d | C3bBbP | |||
C3bBbP | –0.085 (0.685) | – |
0.674 (<0.001)
| – | ||
sTCC |
0.496 (0.012)
| 0.345 (0.091) |
0.643 (<0.001)
|
0.494 (<0.001)
|
Correlation between activated complement products and other biomarkers in the recent injury group
Biomarkers |
n
| C4d | C3bBbP | sTCC |
---|---|---|---|---|
IL-1β | 112 |
0.397 (<0.001)
|
0.232 (0.014)
|
0.297 (0.001)
|
IL-6 | 112 |
0.364 (<0.001)
|
0.235 (0.013)
|
0.268 (0.004)
|
IL-8 | 112 |
0.355 (<0.001)
| 0.183 (0.054) |
0.372 (<0.001)
|
TNF-α | 112 |
0.547 (<0.001)
|
0.317 (0.001)
|
0.391 (<0.001)
|
sGAG | 181 | 0.108 (0.148) | 0.092 (0.218) | 0.132 (0.077) |
ARGS | 111 | −0.023 (0.811) | −0.113 (0.238) | 0.176 (0.065) |
COMP | 112 | −0.019 (0.845) | −0.149 (0.116) | −0.057(0.549) |
C2C | 164 |
−0.181 (0.020)
| −0.101 (0.197) | −0.085 (0.279) |
Osteocalcin | 112 |
0.265 (0.005)
|
0.192 (0.043)
| 0.016 (0.871) |
SPARC | 112 |
0.476 (<0.001)
|
0.221 (0.019)
|
0.401 (<0.001)
|
Osteopontin | 112 | 0.167 (0.079) | 0.098 (0.302) | 0.165 (0.083) |
Association between activated complement products and MRI findings in the recent injury group
Any OC fracture (n = 67) | vs. | No OC fracture (n = 31) | vs. | OC fracture with disrupted cortical bone (n = 38) | vs. | OC fracture without disrupted cortical bone (n = 29) | |
---|---|---|---|---|---|---|---|
Mean (95 % CI) |
p value | Mean (95 % CI) |
p value | Mean (95 % CI) |
p value | Mean (95 % CI) | |
C4d | 38.90 (32.01–47.29) |
0.014
| 23.92 (15.17–37.70) |
0.004
| 45.42 (33.95–60.79) |
0.025
| 31.76 (25.00–40.35) |
C3bBbP | 235.61 (203.19–273.15) | 0.478 | 213.60 (162.33–281.06) | 0.612 | 237.30 (195.79–287.61) | 0.637 | 233.35 (182.64–298.19) |
sTCC | 12.81 (11.35–14.47) |
0.004
| 9.27 (7.20–11.94) |
<0.001
| 14.26 (12.20–16.68) | 0.056 | 11.13 (9.20–13.46) |
ACL injury (n = 60) | vs. | No ACL injury (n = 38) | |||||
Mean (95 % CI) |
p value | Mean (95 % CI) | |||||
C4d | 34.34 (28.39–41.52) | 0.418 | 31.86 (20.87–48.66) | ||||
C3bBbP | 231.42 (198.93–269.28) | 0.417 | 223.67 (174.62–286.48) | ||||
sTCC | 11.53 (10.26–12.97) | 0.885 | 11.61 (9.08–14.85) | ||||
Meniscal tear (n = 43) | vs. | No meniscal tear (n = 55) | |||||
Mean (95 % CI) |
p value | Mean (95 % CI) | |||||
C4d | 29.36 (21.57–39.98) | 0.565 | 36.86 (28.42–47.80) | ||||
C3bBbP | 204.27 (172.78–241.49) | 0.399 | 249.23 (205.21–302.69) | ||||
sTCC | 9.91 (8.46–11.62) |
0.013
| 13.05 (11.08–15.37) |